What Is Epithalon?
Epithalon (Ala-Glu-Asp-Gly, abbreviated AEDG) is a synthetic linear tetrapeptide, one of a family of "short peptide bioregulators" developed at the St. Petersburg Institute of Bioregulation and Gerontology. It was designed to reproduce, in a chemically defined form, the reported bioregulatory activity of epithalamin, a complex and undefined peptide extract of the pineal gland.
Because it is small, defined, and derived from a pineal extract, Epithalon has been studied as a probe of pineal and circadian biology and, most prominently, as a tool compound in telomerase and cellular-senescence research. It is an experimental research peptide with no FDA or EMA approval; the bulk of the evidence is preclinical, and the limited human data derive almost entirely from Russian research groups.
Peptide Profile
Full Name: Epithalon / Epitalon (AEDG)
Sequence: Ala-Glu-Asp-Gly
Molecular Formula: C14H22N4O9
Molecular Weight: ~390.35 g/mol
CAS Number: 307297-39-8
Origin: Synthetic tetrapeptide modeled on the pineal extract epithalamin
Mechanism of Action
The proposed mechanisms below are drawn from the primary literature. Most derive from in vitro and animal work by one principal research program, and independent replication is limited; some findings, notably melatonin effects, are not uniformly reproduced.
Telomerase Induction and Telomere Elongation
In telomerase-negative human fetal fibroblast cultures, Epithalon was reported to induce expression of the telomerase catalytic subunit (hTERT), restore telomerase activity, and lengthen telomeres, allowing treated cells to complete roughly ten additional divisions, described as "overcoming" the normal division (Hayflick) limit. This is the most-cited mechanistic claim and is specifically an in vitro human cell-culture observation.
Pineal and Melatonin Regulation
Consistent with its epithalamin-derived origin, Epithalon has been studied as a modulator of pineal function, with reported effects on melatonin-synthesis machinery. An important caveat: at least one independent group reported no effect on melatonin secretion in isolated pineal preparations, so the melatonin mechanism is not firmly established.
Circadian and Neuroendocrine Bioregulation
In aged animal models, the peptide has been associated with restoration of more youthful circadian patterns of cortisol and melatonin secretion and normalization of age-shifted neuroendocrine rhythms, framed within the research group's broader "peptide theory of ageing."
Gene-Expression and Antioxidant Effects
Short peptides of this family are proposed to interact with regulatory regions of DNA and modulate transcription, and several animal studies report antioxidant activity such as reduced lipid peroxidation. These mechanisms are mechanistically plausible but remain preclinical.
Research Overview
Epithalon has been investigated across cell culture, invertebrate, and rodent models, with a small body of Russian clinical work in retinal disease. The table summarizes what published studies reported.
| Research Area | Key Findings | Study Type |
|---|---|---|
| Telomerase / Telomere Biology | Induced hTERT expression, telomerase activity, and telomere elongation, with treated cells making about ten extra divisions past the normal limit | In vitro (human fibroblasts) |
| Lifespan (Invertebrate) | Extended Drosophila melanogaster lifespan by roughly 11-16% at very low concentrations | In vivo (insect) |
| Lifespan & Tumor Incidence (Rodent) | In female SHR mice, increased maximum and late-survivor lifespan, fewer chromosome aberrations, and lower leukemia incidence versus controls | In vivo (mouse) |
| Carcinogenesis / Metastasis | In female C3H/He mice, decreased number of mice with malignant tumors and reduced development of metastases | In vivo (mouse) |
| Retina / Neuroprotection (Preclinical) | In rats with hereditary pigmentary retinal dystrophy, preserved retinal morphology and bioelectrical activity versus controls | In vivo (rat) |
| Retina (Clinical, Russian) | An open-label report in retinitis pigmentosa described improved retinal function on electroretinography in a majority of cases | Small uncontrolled human study |
Much of the foundational Epithalon work originates from a single research program (Khavinson and Anisimov, St. Petersburg). Some in vitro findings are cited more broadly, but the overall evidence base remains concentrated and largely preclinical. Reported longevity and anti-aging effects are model-system observations and should not be read as demonstrated human health outcomes.
Common Areas of Research Interest
Interest in Epithalon spans cellular-aging, chronobiology, and oncostatic research domains.
- Cellular senescence and telomere maintenance, Epithalon is a frequently cited tool compound in telomerase-activation and Hayflick-limit research
- Biogerontology and longevity modeling, reported lifespan effects in Drosophila and mice make it a recurring agent in geroprotector screening
- Pineal and circadian neuroendocrinology, studied as a probe of pineal peptide signaling and age-related circadian rhythm decline
- Oncostatic and anti-carcinogenesis models, a recurrent finding of reduced spontaneous tumor and metastasis burden in tumor-prone mouse strains
- Retinal degeneration and neuroprotection, the strongest applied-research thread, spanning a rat model and small Russian clinical reports
- Peptide epigenetics and gene regulation, interest in short peptides as sequence-specific transcriptional modulators
Pharmacokinetics
Pharmacokinetic data for Epithalon are limited and largely absent for humans; the notes below are inference from peptide chemistry and preclinical work rather than measured human values.
As a small linear tetrapeptide, Epithalon has no protective secondary structure and is expected to be rapidly hydrolyzed by serum and tissue peptidases, predicting a very short plasma half-life on the order of minutes, though rigorous published human values are not available. Most animal studies used subcutaneous injection.
Reported activity at extraordinarily low concentrations in some models, if real, suggests a signaling- or transcription-mediated action rather than a stoichiometric one, but this is inference rather than measured pharmacokinetics. No validated ADME, bioavailability, or clearance dataset exists in the peer-reviewed record, and any dosing framework should be treated as experimental.
Comparison to Similar Peptides
Epithalon sits within the St. Petersburg family of peptide bioregulators and is best understood alongside its parent extract and a companion peptide.
| Feature | Epithalon (AEDG) | Epithalamin | Thymalin |
|---|---|---|---|
| Origin | Synthetic defined tetrapeptide | Undefined pineal-gland extract | Thymus-gland peptide extract |
| Chemical Definition | Fully characterized, single sequence | Complex mixture | Complex mixture |
| Primary Research Focus | Telomerase, lifespan, circadian, retina | Pineal neuroendocrine aging, lifespan | Immune restoration in aging |
| Proposed Mechanism | hTERT/telomerase induction; circadian bioregulation | Broad pineal neuroendocrine modulation | Thymic / immune peptide bioregulation |
| Research Volume | Moderate, concentrated in one program | Older, foundational, mostly Russian | Mostly Russian; paired in aging studies |
Frequently Asked Questions
Sources & References
- Khavinson VKh, Bondarev IE, Butyugov AA. "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells." Bull Exp Biol Med. 2003;135(6):590-2. PubMed
- Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. "Peptide promotes overcoming of the division limit in human somatic cell." Bull Exp Biol Med. 2004;137(5):503-6. PubMed
- Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. "Effect of epitalon on the lifespan increase in Drosophila melanogaster." Mech Ageing Dev. 2000;120(1-3):141-9. PubMed
- Anisimov VN, Khavinson VKh, Popovich IG, et al. "Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice." Biogerontology. 2003;4(4):193-202. PubMed
- Kossoy G, Anisimov VN, Ben-Hur H, et al. "Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice." In Vivo. 2006;20(2):253-7. PubMed
- Khavinson VKh, Razumovskii MI, Trofimova SV, et al. "Effect of epithalon on age-specific changes in the retina in rats with hereditary pigmentary dystrophy." Bull Exp Biol Med. 2002;133(1):87-9. PubMed
- Khavinson V, Razumovsky M, Trofimova S, et al. "Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa." Neuro Endocrinol Lett. 2002;23(4):365-8. PubMed
- Khavinson VKh. "Peptides and Ageing." Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PubMed
Explore Epithalon
Available for research purposes. Third-party tested for purity and identity.
View Epithalon — Starting at $60This product is intended for research and laboratory use only. It is not intended for human consumption.